Aldosterone Antagonist Therapy and Mortality in Patients With STEMI Without Heart Failure

This systematic review and meta-analysis of 10 randomized clinical trials explores the role of treatment with aldosterone antagonists in patients with ST-segment elevation myocardial infarction (STEMI) without heart failure or left ventricular ejection fraction greater than 40%.
Source: JAMA Internal Medicine - Category: Internal Medicine Source Type: research